As a senior associate in our Intellectual Property team in Paris, I advise and assist our French and international clients with respect to patent matters in various technical fields, with a particular expertise in contentious patent issues in the pharmaceutical sector.
Working as Counsel in our Paris Intellectual Property Group, I draw on both my R&D engineering experience and on my registered French and European patent attorney experience to advise our clients on all phases of patent litigation matters.
I am partner in the International IP Group specialising in litigation of patents and related rights and providing strategic advice on issues in connection with the broader IP, commercial and regulatory environment in the life sciences, healthcare and retail and consumer sectors.
February has seen a step up in the hearings listed in the UPC Hearings Calendar with three listed for the Court of Appeal:
14 February: Juul Labs International Inc. vs NJOY Netherlands BV – RoP 220.2
15 February: Guangdong OPPO Mobile Telecommunications Corp. Ltd. and OROPE Germany GmbH vs. Panasonic Holdings Corporation – RoP 220.1 c)
20 February: Netgear Inc et al. v Huawei Technologies Co. Ltd – appeal from JR decision to refuse a 333.1 RoP request (allowed following discretionary review 202.3 RoP)
And two for Paris:
6 February/Central Division - Neo Wireless GmbH & Co. KG vs Toyota Motor Europe NV/SA – preliminary objection in the revocation action
15 February/Local Division – Novawell v C-Kore Systems Limited – review of an order to preserve evidence - 197.3 RoP
We attended the C-Kore/Novawell hearing last week which was the review of the first preservation of evidence order of the Paris Local Division made in November by the same panel of judges (Ms. Camille Lignières (judge-rapporteur), Ms. Carine Gillet and Ms. Alima Zana of the Milan Local Division).